Abstract:Intraocular pressure (IOP) has a tendency to fluctuate throughout the day, reaching its peak in the early morning in healthy subjects or glaucoma patients. Likewise, histamine tone also fluctuates over time, being lower at nighttime. Numerous studies have demonstrated a correlation between short-term IOP fluctuation and glaucoma progression; however, it has not yet been determined whether histamine plays a role in IOP fluctuations. The aim of this research was to establish the distribution of the histamine receptor proteins and respective mRNAs in the eye by western blot, immunohistochemistry and RT-PCR in New Zealand rabbits. Furthermore, we used a transient ocular hypertension (OHT) model induced by injection of 50 µL of 5% hypertonic saline into the vitreous and a stable OHT model (100 µL 0.1% carbomer in the anterior chamber) to address the potential IOP-lowering ability of H₃ receptor (H₃R) antagonists (ciproxifan, DL76 and GSK189254). IOPs were performed with a Tono-Pen at baseline and 60, 120 and 240 min post treatment after transient OHT induction and, every day for 12 days in the stable OHT model. All histamine receptor subtypes were localized in the rabbit retina and ciliary body/trabecular meshwork. All the treatments lowered IOP in a dose-dependent fashion between 0.3% and 1%. More specifically, the effects were maximal with ciproxifan at 60 min post-dose (IOP60 change = -18.84 ± 4.85 mmHg, at 1%), remained stable until 120 min (IOP120 change = -16.38 ± 3.8 mmHg, at 1%) and decayed thereafter to reach baseline values at 240 min. These effects were highly specific and dependent on histamine release as pre-treatment with imetit (H₃R agonist, 1%) or pyrilamine (H₁R antagonist, 1%) largely blocked ciproxifan-mediated effects. Color Doppler ultrasound examination was performed to evaluate changes in ophtalmic artery resistivity index (RI) before and after repeated dosing with DL 76, GSK189254, ciproxifan and timolol. Chronic treatments with H₃R antagonists and timolol improved the vascular performance of ophthalmic arteries and reduced retinal ganglion cell death. Oxidative stress was also reduced and measured 8-Hydroxy-2'-deoxyguanosine (8OHdG) expression, and by dihidroethydium (DHE) staining. These results demonstrated that the histamine system participates in IOP regulation and that H₃R antagonists could represent a future promising therapy for glaucoma. Further studies should be focused on the long-term IOP circadian fluctuations.

[Suppressing Effect of Isoforskolin and Forskolin on Ocular Hypertension in Rabbits].

Effects of Betaxolol Hydrochloride Cationic Liposomes on Intraocular Pressure, Blood Pressure and Heart Rate in Rabbits

The effect of H-1152 on IOP and trabecular meshwork structure in Rabbit

Influence of saffron extract on the retina of rabbit with chronic ocular hypertension

Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma

Different Effects of Topical Prazosin and Pilocarpine on Uveoscleral Outflow in Rabbit Eyes

Intraocular Pressure-Lowering Effect of Tetrandrine and Timolol on Rats with Ocular Hypertension

Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits.

Effect of Acute Intraocular Pressure Elevation on Blood Flow Velocity and Resistance in the Rabbit Ophthalmic Artery

Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension.

Inhibition by brimonidine of forskolin-induced nitric oxide synthase expression in human ciliary bodies in vitro.

Effect of CO 2 Laser Sclerectomy with Iridectomy on Ocular Hypertension in Rabbits

Effects of D- and L-Isomers of Timolol on Retinal and Choroidal Blood Flow in Ocular Hypertensive Rabbit Eyes

Regulation of IOP and Retinal Degeneration by GYY 4137 in Carbomer-Induced OHT Rabbits, In vivo

A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.

Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma

Effects of Timolol and Brimonidine Eyedrops on Rabbit Ocular Surface

Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways

Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.

Acute ocular hypertension of rabbits induced by cauterizing vortex veins

Effect of Crocus Sativus Extract on Number of Optic Nerve Axons in Rabbits with Chronic Intraocular Hypertension